Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-01 Sale |
2023-06-05 8:12 pm |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $32.6 | $1,630,070 | 2,755,121 (Direct) |
View |
| 2023-06-02 Sale |
2023-06-05 8:07 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Bodenrader Mark See Remarks |
1,895 | $32.95 | $62,440 | 19,721 (Direct) |
View |
| 2023-05-04 Sale |
2023-05-08 4:24 pm |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $31.47 | $1,573,434 | 2,805,121 (Direct) |
View |
| 2023-04-11 Sale |
2023-04-13 4:48 pm |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $25.06 | $1,253,130 | 2,855,121 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 4:15 pm |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $27.12 | $1,355,947 | 5,810,538 (Direct) |
View |
| 2023-02-07 Sale |
2023-02-08 8:27 pm |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $33.13 | $1,656,401 | 3,259,925 (Direct) |
View |
| 2023-01-05 Sale |
2023-01-06 5:04 pm |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $29.94 | $1,496,871 | 3,005,121 (Direct) |
View |
| 2022-12-09 Sale |
2022-12-13 4:44 pm |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $26.67 | $1,333,300 | 3,055,121 (Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 4:28 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
25,000 | $30 | $750,005 | 167,765 (Direct) |
View |
| 2022-10-04 Sale |
2022-10-06 4:59 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
25,000 | $30 | $750,000 | 192,765 (Direct) |
View |
| 2022-09-12 Sale |
2022-09-14 5:10 pm |
Cerevel Therapeutics Holdings Inc. | CERE | PATRICK DEVAL L Director |
47,705 | $30.78 | $1,468,422 | 42,685 (Direct) |
View |
| 2022-09-08 Sale |
2022-09-12 4:24 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
19,210 | $32.5 | $624,325 | 365,009 (Direct) |
View |
| 2022-08-22 Sale |
2022-08-24 4:05 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
9,605 | $32.5 | $312,163 | 384,219 (Direct) |
View |
| 2022-08-16 Purchase |
2022-08-18 5:10 pm |
Cerevel Therapeutics Holdings Inc. | CERE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director |
1,425,000 | $35 | $49,875,000 | 106,511,727 (Indirect) |
View |
| 2022-08-15 Sale |
2022-08-17 4:15 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
9,606 | $34.12 | $327,757 | 393,824 (Direct) |
View |
| 2022-08-10 Sale |
2022-08-12 4:15 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
55,000 | $40.5 | $2,227,624 | 217,765 (Direct) |
View |
| 2022-08-05 Sale |
2022-08-09 9:23 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
30,000 | $34.25 | $1,027,500 | 232,244 (Direct) |
View |
| 2022-08-08 Sale |
2022-08-09 9:18 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Akamine Scott Chief Legal Officer |
10,000 | $40 | $400,001 | 271,762 (Direct) |
View |
| 2022-08-05 Sale |
2022-08-09 8:59 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
57,635 | $34.54 | $1,990,804 | 826,071 (Direct) |
View |
| 2022-07-20 Sale |
2022-07-22 4:15 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
25,000 | $30 | $750,000 | 142,474 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-07 Other |
2023-06-12 6:05 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | BAIN CAPITAL INVESTORS LLC BC Perception Holdings LP BCPE Perception GP LLC Bain Capital Fund XII LP Bain Capital Partners XII LLC 10% Owner |
432,627 | $0 | 60,632,356 (Indirect) |
View |
| 2023-06-07 Option Award |
2023-06-09 5:09 pm |
N/A 2033-06-07 |
Cerevel Therapeutics Holdings Inc. | CERE | Gordon Christopher R Director 10% Owner |
17,062 | $0 | 60,649,418 (Direct) |
View |
| 2023-06-07 Other |
2023-06-09 5:09 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Gordon Christopher R Director 10% Owner |
432,627 | $0 | 60,649,418 (Indirect) |
View |
| 2023-06-07 Option Award |
2023-06-09 5:07 pm |
N/A 2033-06-07 |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
17,062 | $0 | 60,649,418 (Direct) |
View |
| 2023-06-07 Other |
2023-06-09 5:07 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
432,627 | $0 | 60,649,418 (Indirect) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:51 pm |
N/A 2033-06-07 |
Cerevel Therapeutics Holdings Inc. | CERE | Sulzberger Gabrielle Director |
17,062 | $0 | 61,633 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:15 pm |
N/A 2033-06-07 |
Cerevel Therapeutics Holdings Inc. | CERE | Giordano Douglas E. Director |
17,062 | $0 | 17,062 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:15 pm |
N/A 2033-06-07 |
Cerevel Therapeutics Holdings Inc. | CERE | Mckernan Ruth Director |
17,062 | $0 | 17,062 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:15 pm |
N/A 2033-06-07 |
Cerevel Therapeutics Holdings Inc. | CERE | PATRICK DEVAL L Director |
17,062 | $0 | 17,062 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:15 pm |
N/A 2033-06-07 |
Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director |
17,062 | $0 | 59,872 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:15 pm |
N/A 2033-06-07 |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
17,062 | $0 | 647,928 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 8:15 pm |
N/A 2033-06-01 |
Cerevel Therapeutics Holdings Inc. | CERE | ALTSCHULLER Susan Chief Financial Officer |
154,889 | $0 | 154,889 (Direct) |
View |
| 2023-06-01 Exercise |
2023-06-05 8:12 pm |
N/A 2028-12-24 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $0 | 2,755,121 (Direct) |
View |
| 2023-06-01 Exercise |
2023-06-05 8:12 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $3.5 | 2,755,121 (Direct) |
View |
| 2023-06-01 Exercise |
2023-06-05 8:07 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Bodenrader Mark See Remarks |
4,733 | $0 | 19,721 (Direct) |
View |
| 2023-05-04 Exercise |
2023-05-08 4:24 pm |
N/A 2028-12-24 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $0 | 2,805,121 (Direct) |
View |
| 2023-05-04 Exercise |
2023-05-08 4:24 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $3.5 | 2,805,121 (Direct) |
View |
| 2023-04-11 Exercise |
2023-04-13 4:48 pm |
N/A 2028-12-24 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $0 | 2,855,121 (Direct) |
View |
| 2023-04-11 Exercise |
2023-04-13 4:48 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $3.5 | 2,855,121 (Direct) |
View |
| 2023-03-02 Exercise |
2023-03-06 4:15 pm |
N/A 2028-12-24 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $0 | 5,810,538 (Direct) |
View |
| 2023-03-02 Exercise |
2023-03-06 4:15 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $3.5 | 5,810,538 (Direct) |
View |
Ownership |
2023-02-14 5:52 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
0 | $0 | 630,866 (Indirect) |
View |
| 2022-12-21 Ownership |
2023-02-14 5:52 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
14,270 | $0 | 630,866 (Direct) |
View |
| 2022-10-03 Ownership |
2023-02-14 5:47 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Sulzberger Gabrielle Director |
49,624 | $0 | 14,270 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-08 8:34 pm |
N/A 2033-02-06 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
99,103 | $0 | 99,103 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-08 8:30 pm |
N/A 2033-02-06 |
Cerevel Therapeutics Holdings Inc. | CERE | Tregoning Kathleen See Remarks |
68,124 | $0 | 68,124 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-08 8:29 pm |
N/A 2033-02-06 |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
143,528 | $0 | 143,528 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-08 8:29 pm |
N/A 2033-02-06 |
Cerevel Therapeutics Holdings Inc. | CERE | Akamine Scott Chief Legal Officer |
68,088 | $0 | 68,088 (Direct) |
View |
| 2023-02-07 Exercise |
2023-02-08 8:27 pm |
N/A 2028-12-24 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $0 | 3,259,925 (Direct) |
View |
| 2023-02-07 Exercise |
2023-02-08 8:27 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $3.5 | 3,259,925 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-08 8:27 pm |
N/A 2033-02-06 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
304,804 | $0 | 3,259,925 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-08 8:26 pm |
N/A 2033-02-06 |
Cerevel Therapeutics Holdings Inc. | CERE | Bodenrader Mark See Remarks |
25,097 | $0 | 25,097 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-08 8:25 pm |
N/A 2033-02-06 |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
122,516 | $0 | 122,516 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-08 8:25 pm |
N/A 2033-02-06 |
Cerevel Therapeutics Holdings Inc. | CERE | DiPietro Kenneth Chief Human Resources Officer |
68,662 | $0 | 68,662 (Direct) |
View |
| 2023-01-05 Exercise |
2023-01-06 5:04 pm |
N/A 2028-12-24 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $0 | 3,005,121 (Direct) |
View |
| 2023-01-05 Exercise |
2023-01-06 5:04 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $3.5 | 3,005,121 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-13 4:44 pm |
N/A 2028-12-24 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $0 | 3,055,121 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-13 4:44 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY CEO and Chairperson |
50,000 | $3.5 | 3,055,121 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-03 4:28 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
25,000 | $0 | 167,765 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-03 4:28 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
10,018 | $3.5 | 167,765 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-03 4:28 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
14,982 | $10.28 | 167,765 (Direct) |
View |
| 2022-10-04 Exercise |
2022-10-06 4:59 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
25,000 | $0 | 192,765 (Direct) |
View |
| 2022-10-04 Exercise |
2022-10-06 4:59 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
10,018 | $3.5 | 192,765 (Direct) |
View |
| 2022-10-04 Exercise |
2022-10-06 4:59 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
14,982 | $10.28 | 192,765 (Direct) |
View |
| 2022-09-12 Exercise |
2022-09-14 5:10 pm |
N/A 2031-02-01 |
Cerevel Therapeutics Holdings Inc. | CERE | PATRICK DEVAL L Director |
47,705 | $0 | 42,685 (Direct) |
View |
| 2022-09-12 Exercise |
2022-09-14 5:10 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | PATRICK DEVAL L Director |
47,705 | $12.62 | 42,685 (Direct) |
View |
| 2022-09-08 Exercise |
2022-09-12 4:24 pm |
N/A 2031-06-01 |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
19,210 | $0 | 365,009 (Direct) |
View |
| 2022-09-08 Exercise |
2022-09-12 4:24 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
19,210 | $13.17 | 365,009 (Direct) |
View |
| 2022-08-22 Exercise |
2022-08-24 4:05 pm |
N/A 2031-06-01 |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
9,605 | $0 | 384,219 (Direct) |
View |
| 2022-08-22 Exercise |
2022-08-24 4:05 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
9,605 | $13.17 | 384,219 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-17 4:15 pm |
N/A 2031-06-01 |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
9,606 | $0 | 393,824 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-17 4:15 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
9,606 | $13.17 | 393,824 (Direct) |
View |
| 2022-08-10 Exercise |
2022-08-12 4:15 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
55,000 | $0 | 217,765 (Direct) |
View |
| 2022-08-10 Exercise |
2022-08-12 4:15 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
29,624 | $3.5 | 217,765 (Direct) |
View |
| 2022-08-10 Exercise |
2022-08-12 4:15 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
25,376 | $10.28 | 217,765 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 9:23 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
30,000 | $0 | 232,244 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 9:23 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
30,000 | $3.5 | 232,244 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-09 9:18 pm |
N/A 2031-06-01 |
Cerevel Therapeutics Holdings Inc. | CERE | Akamine Scott Chief Legal Officer |
10,000 | $0 | 271,762 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-09 9:18 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Akamine Scott Chief Legal Officer |
10,000 | $13.17 | 271,762 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 8:59 pm |
N/A 2031-06-01 |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
57,635 | $0 | 826,071 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 8:59 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Ceesay Abraham President |
57,635 | $13.17 | 826,071 (Direct) |
View |
| 2022-07-20 Exercise |
2022-07-22 4:15 pm |
N/A 2029-04-02 |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
25,000 | $0 | 142,474 (Direct) |
View |
| 2022-07-20 Exercise |
2022-07-22 4:15 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
25,000 | $3.5 | 142,474 (Direct) |
View |